Jump to content

Cell and Gene Therapy Development

Cell and Gene Therapy development with Genedata Selector
Optimizing and streamlining your NGS-based assays for cell and gene therapy

Streamline CGT Manufacturing Processes

Genedata Selector enables automation and standardization of NGS-based cell and gene therapy assays.

This out-of-the-box support includes safety assays, sequence characterization, and potency assessment.

Learn in 3 minutes how to accelerate NGS-based biosafety analysis for CGT

Ensure Biosafety of CGTs

When used with NGS data, Genedata Selector provides a comprehensive solution for detecting adventitious agents throughout the CGT development process.

From raw the material to the final product, our platform helps you to ensure the biosafety of cell and gene therapy.

Learn in 3 minutes how to streamline decision-making for safe CGT development

Confirm the Integrity of Viral Vectors

Decision making support provided by Genedata Selector leads to faster and better informed decisions for safe cell and gene therapy development.

Scientists can verify sequence integrity of viral vectors in a simple and automated way.

Learn in 3 minutes how to characterize identity and potency of your cells

Assess Potency with scRNAseq Analysis

Genedata Selector supports single cell RNAseq data analyses to streamline your decision-making using the informative and interactive data display.

Cell populations can be analyzed regarding identity and determine the potency.

Streamline Your NGS-Based Cell and Gene Therapy Development

Request a Demo